506U78
Term · Oncology and biomedicine · MLC-T-ONC-000062
A drug used to treat adults and children aged 1 year and older with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It is used in patients whose cancer has not gotten better or has recurred (come back) after treatment with other anticancer drugs. 506U78 stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called Arranon and nelarabine.
| Identifier | MLC-T-ONC-000062 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Arranon; nelarabine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000062",
"term": "506U78",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults and children aged 1 year and older with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It is used in patients whose cancer has not gotten better or has recurred (come back) after treatment with other anticancer drugs. 506U78 stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called Arranon and nelarabine.",
"synonyms": [
"Arranon",
"nelarabine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/506u78/"
}
Record 99 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.